Abstract
Salvage radiotherapy (SRT) for biochemical recurrence (BCR) following radical prostatectomy (RP) should if possible be added at a prostate-specific antigen (PSA) level of <1-2 ng/mL. The value of positron emission tomography combined with computed tomography (PET/CT) at such low PSA values is not defined. The purpose was to determine what proportion of a well-defined cohort of hormone-naïve patients who were candidates for early salvage radiotherapy had (18)F-choline PET/CT findings suggesting metastases.
Original language | English |
---|---|
Pages (from-to) | 1749-1752 |
Journal | World Journal of Urology |
Volume | 33 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2015 |
Subject classification (UKÄ)
- Urology and Nephrology